<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>418</id><JournalTitle>FORMULATION AND DEVELOPMENT OF DUAL RELEASE MULTIPARTICULATE SYSTEM FOR ACECLOFENAC</JournalTitle><Abstract>The objective of present work was to prepare a dual release drug delivery systems comprising fast and delayed release
pattern using solid dispersion and minitablets of aceclofenac to achieve a desired in vitro and in vivo profile. Aceclofenac solid
dispersions were prepared by solvent evaporation method using PEG 6000 as carrier at different ratios. Based on the In vitro
release studies the formulation ASD-4(1:4 ratios) batch was chosen as optimized batch and incorporated into dual release
capsules of aceclofenac. Aceclofenac mini tablets were prepared using different concentrations of HPMC. Based on the in vitro
release studies formulation contain 40% HPMC batch was chosen as optimized batch and incorporated into dual release
capsules of aceclofenac. The dual release dosage forms were constructed incorporating the optimized batch of solid dispersion
with mini tablets. The prepared dual release dosage form was evaluated for their in vitro and in vivo drug release. The dual
released capsules showed a biphasic in vitro release pattern with initial burst release and sustained release following the quasiFickian diffusion-based release mechanism. It was observed that the developed dual release matrix tablets and pellets follow
first order kinetics obeying fickian diffusion. Bioavailability studies for the optimized dual release formulations were carried
out to assess the pharmacokinetic parameters. The peak plasma concentration (Cmax) was achieved 3h for mini matrix tablets.
The C
max of dual release mini matrix tablets was found to be greater than that of IR and SR dosage forms indicating that higher
plasma concentration could be achieved quicker (3h) than the SR formulation (6h). Thus the absorption lag time associated
with SR formulations could be minimized using these formulations. Further, there was significant increase in AUC 0-Î± in case
of dual release mini matrix tablets than the IR and SR indicating the enhanced absorption of poorly water soluble aceclofenac</Abstract><Email>ganesh_gnk@rediffmail.com</Email><articletype>Research</articletype><volume>5</volume><issue>2</issue><year>2014</year><keyword>Aceclofenac,Solid dispersion,Mini matrix tablets,In Vitro drug release,Pharmacokinetic studies</keyword><AUTHORS>Ganesh GNK,Dhanabal SP,Karri. V.V.S. Narayana Reddy,Gunda Raviteja,Kuppusamy Gowthamarajan</AUTHORS><afflication>Department of Pharmaceutics JSS College of Pharmacy, Udhagamandalam-643001, Tamil Nadu, India.,Department of Phytopharmacy and Pharmacognosy, JSS College of Pharmacy, Udhagamandalam-643001, Tamil Nadu, India,Department of Pharmaceutics JSS College of Pharmacy, Udhagamandalam-643001, Tamil Nadu, India.,Department of Pharmaceutics JSS College of Pharmacy, Udhagamandalam-643001, Tamil Nadu, India.,Department of Pharmaceutics JSS College of Pharmacy, Udhagamandalam-643001, Tamil Nadu, India.</afflication></Article></Articles>